Compare Organic Recyclin with Similar Stocks
Total Returns (Price + Dividend) 
Organic Recyclin for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
Announcements 
Announcement under Regulation 30 (LODR)-Investor Presentation
01-Jun-2026 | Source : BSEIn accordance with Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed a copy of Investor Presentation
Announcement under Regulation 30 (LODR)-Investor Presentation
01-Jun-2026 | Source : BSEIn accordance with Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed a copy of Investor Presentation
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Redemption Of Unlisted Class-2 0% Non-Cumulative Redeemable Preference Shares
22-May-2026 | Source : BSEPlease find enclosed herewith intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Redemption of Unlisted Class-2 0% Non-cumulative Redeemable Preference Shares
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Sarang Bhand (18.1%)
Suhrud Chimanbhai Patel (6.41%)
70.01%
Half Yearly Results Snapshot (Consolidated) - Mar'26
Growth in half year ended Mar 2026 is 149.08% vs -2.95% in Sep 2025
Growth in half year ended Mar 2026 is 7.18% vs 36.22% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 117.13% vs 10.56% in Mar 2025
YoY Growth in year ended Mar 2026 is 60.56% vs -0.64% in Mar 2025






